Subclinical hypothyroidism: How should it be managed?

Treatments in Endocrinology

Volumn 1, Issue 4, 2002, Pages 211-216

  Fatourechi, Vahab ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROID PEROXIDASE; THYROTROPIN; THYROXINE;

BIPOLAR DISORDER; CARDIOVASCULAR RISK; GOITER; HYPOTHYROIDISM; INFERTILITY; LIOTHYRONINE BLOOD LEVEL; PREGNANCY; PRIORITY JOURNAL; REVIEW; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

HUMANS; HYPOTHYROIDISM; THYROTROPIN; THYROXINE;

EID: 0038007606     PISSN: 11756349     EISSN: None     Source Type: Journal    
DOI: 10.2165/00024677-200201040-00002     Document Type: Review

References (52)

1. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-99
2. Fatourechi V. Subclinical thyroid disease. Mayo Clin Proc 2001; 76: 413-6
3. Cooper DS. Clinical practice: subclinical hypothyroidism. N Engl J Med 2001; 345: 260-5
4. Klee GG, Hay ID. Biochemical testing of thyroid function. Endocrinol Metab Clin North Am 1997; 26: 763-75
5. Arem R, Escalante D. Subclinical hypothyroidism: epidemiology, diagnosis, and significance. Adv Intern Med 1996; 41: 213-50
6. 3 in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 2002; 87: 1068-72
7. Chu JW, Crapo LM. The treatment of subclinical hypothyroidism is seldom necessary. J Clin Endocrinol Metab 2001; 86: 4591-9
8. McDermott MT, Ridgway EC. Subclinical hypothyroidism is mild thyroid failure and should be treated. J Clin Endocrinol Metab 2001; 86: 4585-90
9. Michalopoulou G, Alevizaki M, Piperingos G, et al. High serum cholesterol levels in persons with 'high-normal' TSH levels: should one extend the definition of subclinical hypothyroidism? Eur J Endocrinol 1998; 138: 141-5
10. Bakker SJ, ter Maaten JC, Popp-Snijders C, et al. The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. J Clin Endocrinol Metab 2001; 86: 1206-11
11. Bastenie PA, Bonnyns M, Vanhaelst L. Grades of subclinical hypothyroidism in asymptomatic autoimmune thyroiditis revealed by the thyrotropin-releasing hormone test. J Clin Endocrinol Metab 1980; 51: 163-6
12. Sheth JJ, Thakore PB, Trivedi BB, et al. Sub-biochemical hypothyroidism: an exaggerated thyroid stimulating hormone response to thyrotropin releasing hormone. J Assoc Physicians India 1999; 47: 275-9
13. Spencer CA, Schwarzbein D, Guttler RB, et al. Thyrotropin (TSH)-releasing hormone stimulation test responses employing third and fourth generation TSH assays. J Clin Endocrinol Metab 1993; 76: 494-8
14. Canaris GJ, Manowitz NR, Mayor G, et al. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160: 526-34
15. Yildirimkaya M, Ozata M, Yilmaz K, et al. Lipoprotein(a) concentration in subclinical hypothyroidism before and after levo-thyroxine therapy. Endocr J 1996; 43: 731-6
16. Hak AE, Pols HA, Visser TJ, et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000; 132: 270-8
17. Vanderpump MP, Tunbridge WM, French JM, et al. The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid 1996; 6: 155-60
18. Danese MD, Powe NR, Sawin CT, et al. Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. JAMA 1996; 276: 285-92
19. Danese MD, Ladenson PW, Meinert CL, et al. Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab 2000; 85: 2993-3001
20. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999; 341: 549-55
21. Klein RZ, Sargent JD, Larsen PR, et al. Relation of severity of maternal hypothyroidism to cognitive development of offspring. J Med Screen 2001; 8: 18-20
22. Glinoer D. Potential repercussions for the progeny of maternal hypothyroxinemia during pregnancy. Thyroid 2000; 10: 59-62
23. Haggerty Jr JJ, Stern RA, Mason GA, et al. Subclinical hypothyroidism: a modifiable risk factor for depression? Am J Psychiatry 1993; 150: 508-10
24. Haggerty Jr JJ, Prange Jr AJ. Borderline hypothyroidism and depression. Annu Rev Med 1995; 46: 37-46
25. Bohnet HG, Fiedler K, Leidenberger FA, Subclinical hypothyroidism and infertility [letter]. Lancet 1981; 11: 1278
26. Tolino A, Nicotra M, Romano L, et al. Subclinical hypothyroidism and hyperprolactinemia. Acta Eur Fertil 1991; 22: 275-7
27. Strickland DM, Whitted WA, Wians Jr FH. Screening infertile women for subclinical hypothyroidism. Am J Obstet Gynecol 1990; 163: 262-3
28. Joffe RT, Kutcher S, MacDonald C. Thyroid function and bipolar affective disorder. Psychiatry Res 1988; 25: 117-21
29. Ananth J, Wohl M, Ranganath V, et al. Rapid cycling patients: conceptual and etiological factors. Neuropsychobiology 1993; 27: 193-8
30. Terao T. Subclinical hypothyroidism in recurrent mania. Biol Psychiatry 1993; 33: 853-4
31. Cooper DS, Halpern R, Wood LC, et al. L-thyroxine therapy in subclinical hypothyroidism: a double-blind, placebo-controlled trial. Ann Intern Med 1984; 101: 18-24
32. Nystrom E, Caidahl K, Fager G, et al. A double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism. Clin Endocrinol (Oxf) 1988; 29: 63-75
33. Jaeschke R, Guyatt G, Gerstein H, et al. Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? J Gen Intern Med 1996; 11: 744-9
34. Meier C, Staub JJ, Roth CB, et al. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study). J Clin Endocrinol Metab 2001; 86: 4860-6
35. Kong WM, Sheikh M, Lumb P, et al. A randomised controlled trial of thyroxine treatment in mild subclinical hypothyroidism [abstract]. Endocr Soc Annu Meet Prog Abstr 2000; 82: 597
36. Pollock MA, Sturrock A, Marshall K, et al. Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: randomised double blind placebo controlled crossover trial. BMJ 2001; 323: 891-5
37. Lekakis J, Papamichael C, Alevizaki M, et al. Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid 1997; 7: 411-4
38. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995; 43: 55-68
39. Bunevicius R, Prange AJ. Mental improvement after replacement therapy with thyroxine plus triiodothyronine: relationship to cause of hypothyroidism. Int J Neuropsychopharmacol 2000; 3: 167-74
40. Bunevicius R, Kazanavicius G, Zalinkevicius R, et al. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 1999; 340: 424-9
41. Toft AD. Thyroid hormone replacement: one hormone or two? N Engl J Med 1999; 340: 469-70
42. Halfan M, Redman CC. Clinical guideline, part 2: screening for thyroid disease: an update. American College of Physicians. Ann Intern Med 1998; 129: 144-58
43. Ladenson PW, Singer PA, Ain KB, et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med 2000; 160: 1573-5
44. Toft AD. Thyroxine therapy. N Engl J Med 1994; 331: 174-80
45. Moore DC. Natural course of 'subclinical' hypothyroidism in childhood and adolescence. Arch Pediatr Adolesc Med 1996; 150: 293-7
46. Oppenheimer JH, Braverman LE, Toft A, et al. A therapeutic controversy. Thyroid hormone treatment: when and what? J Clin Endocrinol Metab 1995; 80: 2873-83
47. Ayala AR, Wartofsky L. The case for more aggressive screening and treatment of mild thyroid failure. Cleve Clin J Med 2002; 69: 313-20
48. Brent GA. Maternal hypothyroidism: recognition and management. Thyroid 1999; 9: 661-5
49. Walsh JP, Stuckey BG. What is the optimal treatment for hypothyroidism? Med J Aust 2001; 174: 141-3
50. Arafah BM. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med 2001; 344: 1743-9
51. Toft AD. Thyroxine replacement therapy. Ann Acad Med Singapore 1993; 22: 583-6
52. Fatourechi V, Gharib H. Hyperthyroidism following hypothyroidism: data on six cases. Arch Intern Med 1988; 148: 976-8